Alivus Life Sciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	25,123	23,869	22,832	21,612	21,232	18,852
Revenue Growth (YoY)	10.48%	4.54%	5.64%	1.79%	12.63%	22.63%
Cost of Revenue	11,282	11,308	10,399	10,469	10,677	9,342
Gross Profit	13,840	12,561	12,433	11,144	10,555	9,509
Selling, General & Admin	2,799	2,705	2,701	1,896	1,744	1,553
Other Operating Expenses	3,211	3,012	2,976	2,819	2,643	2,005
Operating Expenses	6,722	6,323	6,212	5,136	4,766	3,892
Operating Income	7,119	6,238	6,221	6,008	5,789	5,617
Interest Expense	-53.23	-24.14	-15.46	-5.47	-279.62	-875.47
Interest & Investment Income	200.13	200.13	120.21	157.66	67.81	4.3
Currency Exchange Gain (Loss)	35.79	35.79	-6.37	130.23	76.04	-34.59
Other Non Operating Income (Expenses)	165.14	33.63	0.21	1.68	3.19	3.81
EBT Excluding Unusual Items	7,467	6,483	6,320	6,292	5,657	4,715
Gain (Loss) on Sale of Investments	76.15	76.15	-	-	-	-
Gain (Loss) on Sale of Assets	-18.21	-18.21	-7.04	-5.58	-7.43	-5.84
Pretax Income	7,268	6,541	6,313	6,286	5,649	4,709
Income Tax Expense	1,831	1,685	1,604	1,616	1,462	1,194
Net Income	5,437	4,856	4,709	4,670	4,187	3,516
Net Income to Common	5,437	4,856	4,709	4,670	4,187	3,516
Net Income Growth	23.09%	3.13%	0.84%	11.52%	19.10%	12.29%
Shares Outstanding (Basic)	123	123	123	123	118	108
Shares Outstanding (Diluted)	123	123	123	123	118	108
Shares Change (YoY)	0.01%	0.17%	0.13%	4.25%	9.03%	-
EPS (Basic)	44.33	39.63	38.43	38.11	35.63	32.61
EPS (Diluted)	44.23	39.52	38.38	38.11	35.63	32.61
EPS Growth	23.09%	2.97%	0.71%	6.97%	9.26%	12.29%
Free Cash Flow	-	2,253	2,845	1,432	4,654	3,201
Free Cash Flow Per Share	-	18.34	23.19	11.69	39.60	29.69
Dividend Per Share	-	5.000	22.500	21.000	21.000	-
Dividend Growth	-	-77.78%	7.14%	-	-	-
Gross Margin	55.09%	52.63%	54.45%	51.56%	49.71%	50.44%
Operating Margin	28.34%	26.13%	27.25%	27.80%	27.27%	29.80%
Profit Margin	21.64%	20.35%	20.62%	21.61%	19.72%	18.65%
Free Cash Flow Margin	-	9.44%	12.46%	6.63%	21.92%	16.98%
EBITDA	7,728	6,788	6,691	6,394	6,141	5,940
EBITDA Margin	30.76%	28.44%	29.31%	29.58%	28.92%	31.51%
D&A For EBITDA	609.68	549.75	469.84	386.04	351.91	322.9
EBIT	7,119	6,238	6,221	6,008	5,789	5,617
EBIT Margin	28.34%	26.13%	27.25%	27.80%	27.27%	29.80%
Effective Tax Rate	25.19%	25.76%	25.41%	25.71%	25.88%	25.35%
Revenue as Reported	25,600	24,215	22,953	21,902	21,379	18,860
Advertising Expenses	-	183.7	115.47	90.07	54.96	60.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.